Research in New Technology for Animal Cell Culture
Research in cultured meat for future food industry! The solution to solve meat shortage and the related environmental problems
It is estimated that the world population will reach 9 billion people by 2050 and consume 465 million tons of meat. However, breeding livestock requires huge cost and causes various environmental problems in the process. Recently, "cultured meat" has been drawing attention as a way to solve this future shortage of meat.
MBG Group is the only organization devoting itself to R&D for it and plans to invest 110 billion KRW, aiming to be the world's leading global biotechnology company.
Key Business History
Applied for a patent pertaining to Korea's first animal cell culture
(manufacturing method for patty using mushroom concentrate and culture medium)
Discovered the autogeny of cell tissues that is the base of the production process for cultured meat through cell culturing.
MBG Artificial Cultured Meat New Technology
Aiming to become the best leading biotechnology company in the world, MBG focuses on the development of 'cultured meat', which is one of 2020 core visions.
Source: the homepage of Prof. Marc Forster (in the research team of cultured meat) in Maastrichit University, Netherlands
MBG Artificial Cultured Meat New Technology Introduction
R&D technology of animal cell culture is the high-value-added industry to prepare future food for mankind.
Edible meat obtainable through cell proliferation without the breeding (livestock farming) process
It is expected to solve the various environmental problems caused by livestock industry as well as food shortage
What is Cultured Meat?
Cultured meat is called various names in English, e.g. cultured meat, in-vitro meat, lab-grown meat. It refers to as the meat that is cultured from a cow's cells in a laboratory and safely produced in a large quantity. That is, it is the meat produced by cell engineering.
The Necessity of Cultured Meat
It is expected that the world population will grow to 9 billion by 2050 and the demand for meat will increase by 43% from now.
It requires just a couple of weeks to obtain cultured meat.
Cultured meat requires less methane gas and carbon dioxide (96%), and water, feed, and land (98%) than meat from livestock farming.
Development of Cultured Meat
MBG Research Institute aims to extract the muscular satellite cells of a cow, which are the base material for cultured meat, proliferate and divide them in a medium, and finally produce cultured meat that we can eat.
To this end, our researchers are doing independent R&D to find the optimal conditions for the extraction, proliferation, and division of satellite cells. In addition, we are also focusing on the development of cultured meat by culturing Mesenchymal stem cells and on developing the media that can save the production cost of cultured meat and the substrate suitable for meat culturing.
MBG Culture Meat R&D Development Map
Extract the cells from a calf muscle or placenta
Proliferate the cells and Induce their division
Develop for divided cells and analyze medium and ingredients by medium
Medium* : solution or solid material used to proliferate, preserve, and/or transport microorganisms. It is used to culture the tissues of a microorganism or an animal.
Secure the cells for mass production and develop a customized medium for the economic purpose.
Control the demand of meat with one from livestock farming and laboratory meat (or their mixture).
We have completed Phase 1 and 2 and plan to develop for divided muscle satellite cells.
We plan to develop an MBG-exclusive medium that is economic, efficient and customized to cells.
We are doing R&D work with the aim to mass-produce cultured muscle satellite cells, mesenchymal stem cells, and embryonic stem cells, culture them, and finally develop cultured meat.
Research in New Substance Against Atopy
The development of a treatment for atopic dermatitis!
Proposing a new paradigm for human health and happiness. MBG Group has shifted our viewpoint of atopic dermatitis to a new horizon, developing natural atopic treatments. We have already finished developing a new substance, paper presentation, and patent application. There are only clinical tests left ahead of us. MBG Group has a plan to supply the new substance of atopic treatment to UN free of charge and thus help 300 millions of patients with atopic problems in the world. It presents a new paradigm for biotechnology and will become a company that exists truly for the people and leads the global biotechnology for human health.
Research in New Substance Against Atopy Introduction
Concentrating on the development of a new natural substance for atopic dermatitis
Proved that the efficacy of the new substance on atopic dermatitis
Passed the final test of animal experimentation conducted by the special animal department of Kongju National University
(confirmed that the new substance is effective on atopic diseases of an experimental rat after cell tests related to TNF-Alpha and NO)
It increases the possibility that atopic dermatitis can improve without using a steroid-based drug
Breast Cancer Treatment Development
Development of the New Treatment for Cancer originated in the Natural Substance extracted from Plant Resources
The breast cancer has been known as the most common female cancer since a long time ago in the United States. It is currently known to be the most common female cancer in Korea as well. The MBG research institute has the mission to protect the mankind from the breast cancer that endangers the health of females by using their long clinical experience and the natural resources proved of the safety. It challenges to conquer cancer through the development of the new treatment for cancer with less side effects by sorting out the substances with outstanding cancer treatment effects and establishing the mechanism of action.
Development of the New Treatment for Cancer originated in Natural Substance
The worldwide natural substance drug market is in the size of 50 trillion won, and seems to grow by the average of over 20% every year. Therefore, it is expected to largely contribute to the needs of the consumers who enter the aging society.
Aims to develop the new treatment that targets the breast cancer
Currently performing the cell and animal experiments for the cancer treatment effects and action mechanism through the cooperative research with the special zoology department in Kongju National University
- MCF-7 (Estrogen Positive)
- MDA-MB-231 (Estrogen Negative)
Expects the development of the new treatment originated in the natural substances with less side effects
NK Immune Cell Technology
New Paradigm of Biotechnology, NK Immune Cell Technology !
The MBG group joined hands with Giga Bio which is the bio venture company that possesses the ability to isolate and grow the immune cells and stem cells to cure the incurable diseases such as the cancer which is the most common one in the modern society, of which everyone is scared. It aims to take a leap as a front-runner of the biotechnology bio technology by jointly developing the NK cell technology for all Korean citizens to enjoy the healthy and happy life.
What is NK Cell (Natural Killer Cell)?
It is a type of the white blood cell in blood. It is the immune cell that directly destroys the cancer cell and is known as the natural killer cell.
The NK cell is originally in the human body, which can cure the cancer without any side effect.
Current Progress Status
Jun. 27, 2018 Group-Giga Bio NK Immune Cell Technology Development Investment Agreement MOU Conclusion
NK Roles and Characteristics of Immune Cell
Removes the variant cells that form everyday.
Prevents the reoccurrence and spread of the cancer.
The NK immune cell attacks the cancer cells that cannot be attacked by the T-Cell.
Can attack the cancer cells in which the antibodies are combined.